UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-24260 AMEDISYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 11-3131700 (State or other jurisdiction of in ...

Amedisys Inc. (NASDAQ:AMED) Q4 2018 Earnings Conference Call February 28, 2019 10:00 AM ET Company Participants Nick Muscato - Vice President, Strategic Finance Paul Kusserow - President and Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Dave Kemmerly - General Counsel and Vice President, Government Affairs Conference Call Participants Brian Tanquilut - Jefferies Matt Larew - William Blair Frank Morgan - RBC Capital Markets Joanna Gajuk - Bank of America ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-24260 AMEDISYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 11-3131700 (State or other jurisdiction of incor ...